Theralase® Technologies Inc. (TSXV: TLT) (OTCQB: TLTFF) ("Theralase®" or the "Company"), a clinical-stage pharmaceutical ...
A new meta-analysis of randomized trials and observational studies finds no clear benefit or harm from adjunctive ...
New research in PLOS Pathogens shows that genital epithelial cells from people with asymptomatic HSV-2 infection respond more ...
Clinically relevant reduction in urinary incontinence episodes consistently maintained overtime including in the initial set of patients reaching end of study at 52 weeks Treatment was well tolerated, ...
The FDA hit Amazon with a warning letter for selling unapproved herpes treatments. In July, the agency purchased several of the herpes products available on Amazon's website and found numerous ...
Medical imaging can tell us what is happening in the body, but not always what it means to the patient. Medical semiotics can ...
SHELTON, CT / ACCESS Newswire / October 5, 2026 / NanoViricides, Inc. (NYSE American:NNVC) (the "Company"), a clinical ...
New research suggests the common shingles vaccine may be linked to a lower dementia risk. Scientists explain the surprising ...
It has been billed as one of the biggest medical discoveries in recent history. The shingles vaccine, designed to protect ...
RINVOQ is the first and only systemic medication approved in the European Union to treat adult and adolescent patients with non-segmental vitiligo (NSV) who are candidates for systemic therapy Phase 3 ...
Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) and Sanofi today announced an expansion of their long-standing antibody collaboration, adding multiple next-generation, long-acting antibodies to the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results